ED is the most validated DTC prescription category in existence: high demand, high retention. CareValidate gives your storefront the clinical pathway to compete in it on day one.
Erectile dysfunction treatment was the category that taught the industry how DTC telehealth could work. The need is pervasive, the medication is proven, the clinical pathway is simple, and patients' willingness to seek treatment online is extremely high. The internet removed the biggest barrier: embarrassment.
CareValidate's ED offering is built on the two most established PDE5 inhibitors: sildenafil and tadalafil. We provide the clinical infrastructure, your storefront provides the brand experience that converts and retains patients.
Men in the U.S. affected by ED, roughly 1 in 3 men over age 40
U.S. ED medication market, with DTC telehealth capturing a growing share every year
of men aged 40–70 experience some degree of ED, most have never sought treatment online
The clinical pathway is well-established, conversion economics are understood, and patient retention is inherently strong. Patients who find something that works stay on it. It also has high recurring purchase rates, strong word-of-mouth in men's health communities.
Despite competition from established players, there is significant whitespace. Research suggests that more than half of men affected by ED have not yet tried an online treatment option, meaning the addressable market is far from saturated.
Patient completes questionnaire covering health history and current medications.
Licensed clinician reviews intake.
Medication dispensed and shipped discreetly in plain packaging to the patient's address.
If appropriate, provider prescribes the right drug and dose.
.svg)